Thus, our results provide useful biochemical insights into an in-depth understanding of the SARS-CoV S protein and its potential exploitation for the development of point-of-care detection toolkits, as well as prophylaxis and therapeutics against SARS-CoV infection. Here, PROS1 is linked to severe acute respiratory syndrome.